Hohl Benjamin Insider Trades & Stock Holdings

CHIEF FINANCIAL OFFICER · Enliven Therapeutics, Inc. · Latest filing Sep 17, 2026

Hohl Benjamin, CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc. has 1 Form 4 trade on file since Sep 17, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($303K), net -$303K. Latest filing: disposed of 6.02K shares of $ELVN on Sep 17, 2026 at $50.35.

Trades on file

1

Open-market bought

$0

Open-market sold

$303K

Net open-market

-$303K

Latest filing

Sep 17, 2026

All insider trades by Hohl Benjamin

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 17, 2026	$ELVN	Sell (Open-market sale) 10b5-1	6.02K	$50.35	$303K			-10.1%			CHIEF FINANCIAL OFFICER		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Hohl Benjamin traded

• $ELVN

Frequently asked questions

Has Hohl Benjamin been buying or selling stock?

Hohl Benjamin has 0 open-market purchases and 1 open-market sale on file, net -$303K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Hohl Benjamin's latest insider trade?

disposed of 6.02K shares of $ELVN on Sep 17, 2026 at $50.35.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.